Association of Androgenetic Alopecia with a More Severe Form of COVID-19 Infection

    Dunja Veskovic, Tatjana Roš, Tijana Icin, Kristina Stepanovic, Nebojsa Janjic, Dusan Kuljancic, Sonja Sedlarevic, Dmitar Vlahovic
    TLDR Men with androgenetic alopecia and hypertension may experience more severe COVID-19.
    This study examined the link between androgenetic alopecia (AGA) and COVID-19 severity in 208 male patients, focusing on androgen receptor expression. It found that the Gabrin sign, a marker of AGA, was associated with worse COVID-19 outcomes, indicating a potential connection between androgen levels and disease severity. Hypertension was also identified as a factor related to poor COVID-19 prognosis. The results suggest that both AGA and hypertension may contribute to more severe COVID-19 outcomes, highlighting the need for further research with larger sample sizes to better understand these associations.
    Discuss this study in the Community →

    Research cited in this study

    17 / 17 results

    Related Community Posts Join

    6 / 1000+ results

      community 1 month Pyrilutamide. A non responders story to everything.

      in Research/Science  218 upvotes 2 years ago
      My hairline, I am only 23. This conversation is about a user's experience with treatments for androgenic alopecia, including finasteride, dutasteride, RU, minoxidil, progesterone, melatonin, LLLT, oral minoxidil, and Pyrilutamide. They have tried many treatments over the course of two years without seeing much success, and they are considering getting a hair system as a last resort.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 8 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

      in Research/Science  65 upvotes 1 year ago
      Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.

    Related Research

    2 / 2 results